Yahoo
NYSE - Delayed Quote USD

Solventum Corporation (SOLV)

91.69 -0.75 (-0.81%)
At close: September 4 at 4:00:02 PM EDT
91.69 0.00 (0.00%)
After hours: September 4 at 7:30:06 PM EDT
Trade SOLV on Coinbase
Chart Range Bar
Loading chart for SOLV

What's happening with SOLV?

51m ago
Powered by Yahoo Scout

Solventum (SOLV) has shown strong Q2 performance, with adjusted EPS of $2.55and revenues of $2.21 billion, beating estimates. However, concerns about high debt levels and potential margin pressures persist, leading to mixed analyst ratings and cautious investor sentiment.

Powered by Yahoo Scout
  • Previous Close 92.44
  • Open 91.40
  • Bid 91.76 x 50000
  • Ask 91.84 x 50000
  • Day's Range 91.38 - 92.28
  • 52 Week Range 62.38 - 94.16
  • Volume 576,348
  • Avg. Volume 1,217,212
  • Market Cap (intraday) 15.608B
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) 11.21
  • EPS (TTM) 8.18
  • Earnings Date (est.) Nov 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 93.92

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

www.solventum.com

20,584

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SOLV
15.71%
S&P 500 (^GSPC)
12.75%

1-Year Return

SOLV
26.68%
S&P 500 (^GSPC)
18.71%

3-Year Return

SOLV
0.70%
S&P 500 (^GSPC)
70.93%

5-Year Return

SOLV
0.70%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 2.21B
Earnings 92M
Profit Margin 4.16%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
500M
1B
2B
2B
20.0%
40.0%
60.0%

Analyst Insights

View More

Analyst Price Targets

70.00 Low
93.92 Average
91.69 Current
113.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/6/2026
Analyst UBS
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 95 -> 101

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    17.26%

  • Return on Assets (ttm)

    2.70%

  • Return on Equity (ttm)

    33.96%

  • Revenue (ttm)

    8.31B

  • Net Income Avi to Common (ttm)

    1.43B

  • Diluted EPS (ttm)

    8.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    403M

  • Total Debt/Equity (mrq)

    110.31%

  • Levered Free Cash Flow (ttm)

    489M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: